Free shipping over €250 · Tracked, discreet delivery in Europe

Somatostatin analogue

Lanreotide

Somatuline

Approved medicineNot yet reviewedPeptide

In short: A long-acting somatostatin analogue approved for acromegaly and neuroendocrine tumours.

Regulatory status

  1. Cosmetic ingredient
  2. Research compound
  3. In clinical trials
  4. Approved medicine

Approved as a medicine by the FDA or the EMA for at least one indication. Approval covers the named indication and formulation only.

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Common questions

Is Lanreotide an approved medicine?

Approved medicine. Approved as a medicine by the FDA or the EMA for at least one indication. Approval covers the named indication and formulation only.

How much human research is there on Lanreotide?

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Does UU supply Lanreotide?

No. It appears in the library for reference only, so the field can be read in one place.

More in Gut & weight

Back to the library
  • In trialsuu

    Retatrutide

    GIP, GLP-1 and glucagon receptor agonist

    Early human data
  • Approveduu

    Tirzepatide

    GIP and GLP-1 receptor agonist

    Human trials
  • Approveduu

    Semaglutide

    GLP-1 receptor agonist

    Human trials
  • In trialsuu

    Cagrilintide

    Long-acting amylin analogue

    Human trials
  • Researchuu

    AOD-9604

    Growth hormone fragment

    Mixed evidence
  • Researchuu

    5-Amino-1MQ

    NNMT inhibitor

    Preclinical

The UU library is an educational reference. It is not medical advice, does not make a health claim, and does not tell anyone how to use a compound. UU products are sold for laboratory research use only and are not for human consumption. Regulatory status changes: confirm it with the relevant authority before relying on it.